BioSpace News Archive

A global data analytics and advisory firm, Quantzig, has announced the release of their latest success story on patient engagement analysis for a leading pharma company.

Michael Fraser, Chief Executive Officer of the Association of State and Territorial Health Officials (ASTHO), issued the following statement in response to the Surgeon General’s advisory on marijuana use and its impact on the developing brain:

The drug is manufactured by Gilead Sciences under numerous brand names, such as Truvada, Viread, Atripla, Complera and Stribild.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the promotion of Sri Kosaraju to President, in addition to his current responsibilities as CFO of Penumbra.

Johnson & Johnson (NYSE: JNJ) will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The Grand Hyatt Hotel in New York.

X4 Pharmaceuticals, Inc. announced that, on August 28, 2019, the Compensation Committee of X4’s Board of Directors issued inducement awards to two new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.

Citius Pharmaceuticals, Inc. (“Citius”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that the Company will be presenting at the 4th annual Disruptive Growth Conference on Wednesday, September 4th at 3:40PM EST in Presentation Room A/B.

Inc. magazine today revealed that Legwork is No. 1169 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies.

Geyser Brands Inc. (TSXV:GYSR) (“Geyser Brands” or the “Company”) today released its Q1 financial statements for the three months ended June 30, 2019.

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam, India joint venture, Granules OmniChem Private Limited (GOC) from its joint venture partner, Granules India Limited.